We don't just manage your dose we help you build a foundation that holds
The peptide undergoes rapid first-pass metabolism when absorbed, which is why bioavailability varies significantly by administration route
Reference: Kaplan A, Heatley H, Townend J, et al
Your clinician should explain both the benefits of GLP-1 therapyincluding improved glycaemic control, weight loss, and cardiovascular protectionand the theoretical risks based on animal data
Injectable LIPO-C bypasses first-pass hepatic metabolism, achieving 8595% bioavailability compared to 3050% for oral methionine, choline, and inositol supplements
For TJA, priority endpoints include wound complications, prolonged drainage, hematoma requiring intervention, early readmission, and PJI, with follow-up sufficient to capture early revision risk